International Diabetes Federation: a consensus on Type 2 diabetes prevention

被引:477
作者
Alberti, K. G. M. M. [1 ]
Zimmet, P. [1 ]
Shaw, J. [1 ]
机构
[1] St Marys Hosp, Dept Endocrinol & Metab Med, London W2 1NY, England
关键词
International Diabetes Federation; population; prevention; risk factors; Type; 2; diabetes;
D O I
10.1111/j.1464-5491.2007.02157.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Early intervention and avoidance or delay of progression to Type 2 diabetes is of enormous benefit to patients in terms of increasing life expectancy and quality of life, and potentially in economic terms for society and health-care payers. To address the growing impact of Type 2 diabetes the International Diabetes Federation (IDF) Taskforce on Prevention and Epidemiology convened a consensus workshop in 2006. The primary goal of the workshop and this document was the prevention of Type 2 diabetes in both the developed and developing world. A second aim was to reduce the risk of cardiovascular disease in people who are identified as being at a higher risk of Type 2 diabetes. The IDF plan for prevention of Type 2 diabetes is based on controlling modifiable risk factors and can be divided into two target groups: People at high risk of developing Type 2 diabetes The entire population. Conclusions In planning national measures for the prevention of Type 2 diabetes, both groups should be targeted simultaneously with lifestyle modification the primary goal through a stepwise approach. In addition, it is important that all activities are tailored to the specific local situation. Further information on the prevention of diabetes can be found on the IDF website: http://www.idf.org/prevention.
引用
收藏
页码:451 / 463
页数:13
相关论文
共 56 条
  • [1] Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes - A meta-analysis of randomized clinical trials
    Abuissa, H
    Jones, PG
    Marso, SP
    O'Keefe, JH
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (05) : 821 - 826
  • [2] A risk score for predicting incident diabetes in the Thai population
    Aekplakorn, Wichai
    Bunnag, Pongamorn
    Woodward, Mark
    Sritara, Piyamitr
    Cheepudomwit, Sayan
    Yamwong, Sukit
    Yipintsoi, Tada
    Rajatanavin, Rajata
    [J]. DIABETES CARE, 2006, 29 (08) : 1872 - 1877
  • [3] Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation
    Alberti, KGMM
    Zimmet, P
    Shaw, J
    [J]. DIABETIC MEDICINE, 2006, 23 (05) : 469 - 480
  • [4] American Diabetes Association, DIAB RISK TEST
  • [5] [Anonymous], 2004, INT TXB DIABETES MEL
  • [6] [Anonymous], 2002, World Health Report, 2002: Reducing risks, promoting healthy life
  • [7] Visceral adiposity and risk of type 2 diabetes - A prospective study among Japanese Americans
    Boyko, EJ
    Fujimoto, WY
    Leonetti, DL
    Newell-Morris, L
    [J]. DIABETES CARE, 2000, 23 (04) : 465 - 471
  • [8] Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women
    Buchanan, TA
    Xiang, AH
    Peters, RK
    Kjos, SL
    Marroquin, A
    Goico, J
    Ochoa, C
    Tan, S
    Berkowitz, K
    Hodis, HN
    Azen, SP
    [J]. DIABETES, 2002, 51 (09) : 2796 - 2803
  • [9] OBESITY, FAT DISTRIBUTION, AND WEIGHT-GAIN AS RISK-FACTORS FOR CLINICAL DIABETES IN MEN
    CHAN, JM
    RIMM, EB
    COLDITZ, GA
    STAMPFER, MJ
    WILLETT, WC
    [J]. DIABETES CARE, 1994, 17 (09) : 961 - 969
  • [10] Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial
    Chiasson, JL
    Josse, RG
    Gomis, R
    Hanefeld, M
    Karasik, A
    Laakso, M
    [J]. LANCET, 2002, 359 (9323) : 2072 - 2077